Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX000623 in Diabetic Peripheral Neuropathic Pain
NCT06221241Phase 2Recruiting
- Sponsor
- Jemincare
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX000623 in diabetic polyneuropathy (DPN), sponsored by Jemincare. Started Mar 2024; status: recruiting.
02
Drugs
JMKX000623
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT06221241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06221241.